SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Acutaas Chemicals informs about disclosures

23 Jun 2026 Evaluate
Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and further to intimation dated June 22, 2026, Acutaas Chemicals has informed that the Central Goods & Service Tax & Central Excise (CGST & CE), Anti -evasion Department, Surat, Guijarat have concluded their Inspection/Search on June 23, 2026. The details required to be disclosed under the Listing Regulations read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/1/3762/2026 dated January 30, 2026 are enclosed to this letter as Annexure A.

The above information is a part of company’s filings submitted to BSE.

Acutaas Chemicals Share Price

3291.00 22.30 (0.68%)
25-Jun-2026 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1861.00
Dr. Reddys Labs. 1351.00
Cipla 1439.95
Zydus Lifesciences 1100.70
Lupin 2346.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: